Literature DB >> 6873525

Spontaneous, in vitro, malignant transformation of a basophil/mast cell line.

P E Ball, M C Conroy, C H Heusser, J M Davis, J F Conscience.   

Abstract

It has recently become possible to grow basophil/mast cells in vitro for extended periods of time. Normally, these cultures remain fully dependent upon the presence of an adequate supply of growth factor(s) and the cells express several basophil/mast cell differentiated traits. We report here a case of spontaneous, in vitro, malignant transformation of such a basophil/mast cell line. The transformed cells no longer require the addition of growth factor(s) for continuous proliferation in vitro, and they have become highly tumorigenic in vivo. In contrast, when compared to their untransformed counterparts, they display the same set of differentiated traits, characteristic of immature basophil/mast cells. Thus, the data support the hypothesis that cell transformation results from a decreased sensitivity of precursor cells toward normal growth regulators but does not affect significantly the expression of differentiated functions.

Mesh:

Year:  1983        PMID: 6873525     DOI: 10.1111/j.1432-0436.1983.tb01305.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  10 in total

1.  Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions.

Authors:  A Wodnar-Filipowicz; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 2.  Role of lymphokines in immediate type allergy.

Authors:  B M Stadler; A L de Weck
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Characterization of leukotriene A4 synthase from murine mast cells: evidence for its identity to arachidonate 5-lipoxygenase.

Authors:  T Shimizu; T Izumi; Y Seyama; K Tadokoro; O Rådmark; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

Authors:  I D Diamantis; A P Nair; H H Hirsch; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Altered protein kinase C in a mast cell variant defective in exocytosis.

Authors:  N Mazurek; R Regazzi; C Borner; R Wyss; J F Conscience; P Erne; U Eppenberger; D Fabbro
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

6.  A v-H-ras-dependent hemopoietic tumor model involving progression from a clonal stage of transformation competence to autocrine interleukin 3 production.

Authors:  A P Nair; I D Diamantis; J F Conscience; V Kindler; P Hofer; C Moroni
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

7.  Interleukin-3-dependent expression of the c-myc and c-fos proto-oncogenes in hemopoietic cell lines.

Authors:  J F Conscience; B Verrier; G Martin
Journal:  EMBO J       Date:  1986-02       Impact factor: 11.598

8.  Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody.

Authors:  A J Coyle; K Wagner; C Bertrand; S Tsuyuki; J Bews; C Heusser
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

9.  Reversible abrogation of IL-3 dependence by an inducible H-ras oncogene.

Authors:  E Andrejauskas; C Moroni
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

10.  Interleukin 3-specific tyrosine phosphorylation of a membrane glycoprotein of Mr 150,000 in multi-factor-dependent myeloid cell lines.

Authors:  S Koyasu; A Tojo; A Miyajima; T Akiyama; M Kasuga; A Urabe; J Schreurs; K Arai; F Takaku; I Yahara
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.